Total N=518 | Incomplete revascularisation* n=287 | Complete revascularisation* n=231 | p Value | |
Gender (male) | 76% | 74% | 78% | 0.24 |
Age (years) | 63±12 | 64±13 | 62±12 | 0.02 |
Obesity (BMI≥30 kg/m2) | 16% | 17% | 15% | 0.41 |
Diabetes | 12% | 14% | 10% | 0.15 |
Hypercholesterolaemia† | 17% | 19% | 15% | 0.30 |
Hypertension‡ | 37% | 40% | 34% | 0.17 |
Current smoker | 44% | 43% | 45% | 0.58 |
Family history of CAD | 38% | 38% | 38% | 0.90 |
Presenting in Killip class≥2 | 7% | 10% | 4% | 0.006 |
Culprit vessel | ||||
Left main | 1% | 1% | 2% | 0.50 |
RCA | 42% | 39% | 45% | 0.20 |
LAD | 41% | 46% | 35% | 0.02 |
LCx | 16% | 14% | 18% | 0.19 |
Three-vessel CAD | 33% | 42% | 22% | <0.001 |
eGFR ≤60 mL/min/1.73 m² | 13% | 15% | 9% | 0.04 |
Troponin T level | 4.57 (IQR 1.77–8.93) | 4.91 (IQR 1.86–9.22) | 4.40 (IQR 1.58–8.60) | 0.28 |
Peak cardiac troponin T level ≥3.5 µg/L | 59% | 61% | 56% | 0.18 |
LV ejection fraction | 47±10 | 46±10 | 47±10 | 0.07 |
LV ejection fraction ≤40% | 28% | 31% | 25% | 0.13 |
Blood pressure at discharge | ||||
Systolic | 116±17 | 115±16 | 118±18 | 0.10 |
Diastolic | 70±11 | 69±10 | 71±12 | 0.12 |
Medication at discharge | ||||
Beta-blocker | 93% | 92% | 94% | 0.36 |
Aspirin | 96% | 96% | 97% | 0.75 |
Clopidogrel | 99% | 99% | 99% | 0.80 |
ACE inhibitor/ARB | 96% | 96% | 97% | 0.55 |
Statin | 98% | 98% | 98% | 0.71 |
*Complete revascularisation was defined as treating all present significant coronary artery stenosis ≥70% during primary PCI or before discharge.
†Serum total cholesterol ≥230 mg/dL and/or serum triglycerides ≥200 mg/dL or treatment with lipid-lowering drugs.
‡Defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg and/or the use of antihypertensive medication.
ARB, angiotensin receptor blockers; BMI, body mass index; CAD, coronary artery disease; eGFR, glomerular filtration rate estimated using the Cockroft-Gault formula; LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; LV, left ventricle; PCI, percutaneous coronary intervention; RCA, right coronary artery; STEMI, ST-segment elevation myocardial infarction.
A two-sided p value of <0.05 was considered statistically significant.